There is a new recommendation from the Standing Vaccination Commission (Stiko) for AstraZeneca: The vaccine should be coupled with Biontech or Moderna in the future.
Berlin – There is a lot of turmoil about the AstraZeneca vaccine: First, the vaccine with the vaccine is said to have triggered thromboses in young people. Therefore, the vaccine is only recommended for people over 60 years of age. Now the Standing Vaccination Commission (Stiko) is in favor of crossing the preparation with an mRNA vaccine.
A study by Oxford University found that the combination of AstraZeneca with Biontech or Moderna* Achieves higher antibody production than double vaccination of AstraZeneca. The sequence of vaccinations is irrelevant. In total, over nine million Germans received the AstraZeneca vaccine when they were first vaccinated. Will everyone now get an mRNA vaccine when they have a second vaccination?
Cross-vaccination only applies to first-time vaccinations. Anyone who has already received both AstraZeneca cans is not affected by the new recommendation. Whether people with a double AstraZeneca vaccination are less protected and what the new recommendation of the Stiko for cross vaccination means*, find out at 24hamburg.de. * 24hamburg.de is an offer from IPPEN.MEDIA.